Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Large Decline in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a large decrease in short interest in the month of October. As of October 15th, there was short interest totaling 28 shares, a decrease of 56.9% from the September 30th total of 65 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 1,902 shares, the short-interest ratio is presently 0.0 days.

Innovator IBD Breakout Opportunities ETF Trading Down 1.6%

BOUT traded down $0.65 during trading on Friday, hitting $40.62. The stock had a trading volume of 1,823 shares, compared to its average volume of 3,481. The firm has a market cap of $14.22 million, a PE ratio of 28.69 and a beta of 1.04. Innovator IBD Breakout Opportunities ETF has a 12 month low of $35.05 and a 12 month high of $49.41. The company has a 50 day simple moving average of $43.05 and a 200-day simple moving average of $43.38.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.